ArticleACS nano2025

SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation.

Chengyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.